Pathogenesis, prevention, and treatment of diabetic nephropathy
- 1 July 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 352 (9123) , 213-219
- https://doi.org/10.1016/s0140-6736(98)01346-4
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Treatment of hypertensive patients with diabetesThe Lancet, 1998
- Effects of Lisinopril and Nifedipine on the Progression to Overt Albuminuria in IDDM Patients With Incipient Nephropathy and Normal Blood PressureDiabetes Care, 1998
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.Journal of Clinical Investigation, 1997
- Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathyKidney International, 1996
- Diabetic Renal Disease: The Quest for Normotension—and BeyondDiabetic Medicine, 1995
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Effects of Long-Term Enalapril Treatment on Persistent Microalbuminuria in Well-Controlled Hypertensive and Normotensive NIDDM PatientsDiabetes Care, 1994
- Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.Hypertension, 1993
- Disparities in Incidence of Diabetic End-Stage Renal Disease According to Race and Type of DiabetesNew England Journal of Medicine, 1989
- Glomerular Lesions and Urinary Albumin Excretion in Type I Diabetes without Overt ProteinuriaNew England Journal of Medicine, 1989